Article Versions Notes

Njoroge W, Hernández ACH, Musa FI, Butler R, Harper AGS, Yang Y. The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models. Pharmaceutics. 2021; 13(3):340. https://doi.org/10.3390/pharmaceutics13030340

Njoroge, Wanjiku, Andrea C. Hernández Hernández, Faiza Idris Musa, Robert Butler, Alan G. S. Harper, and Ying Yang. 2021. "The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models" Pharmaceutics 13, no. 3: 340. https://doi.org/10.3390/pharmaceutics13030340

Njoroge, W., Hernández, A. C. H., Musa, F. I., Butler, R., Harper, A. G. S., & Yang, Y. (2021). The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models. Pharmaceutics, 13(3), 340. https://doi.org/10.3390/pharmaceutics13030340